Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc

Bullboard Posts

Comment by HCallahann44on Sep 18, 2020 10:53am

237 Views

Post# 31580963

RE:RE:Generational wealth once again

Thanks Westcoast...I own approx. 34k share...maybe not enough to generate generational wealth...but enough to keep me up at night when the share price starts disintegrating...you seem like a savvy guy so curious about your other picks. I would proffer EMX--a royalty generator in the gold and copper space...there Serbian royalty alone is worth twice the market cap...well respected leadership with very large individual ownership....PM home run hitter hedge fund manager Paul Stephens owns a big chunk...check his track record....good luck to us all.

Bullboard Posts

Changing Europe’s dependency on HREE from China